<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:59:29Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7787468" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7787468</identifier>
        <datestamp>2021-01-14</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7787468</article-id>
              <article-id pub-id-type="pmcid">PMC7787468</article-id>
              <article-id pub-id-type="pmc-uid">7787468</article-id>
              <article-id pub-id-type="pmid">33406106</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-20-25510</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0244706</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Infectious Disease Epidemiology</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Infectious Disease Epidemiology</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Viral Diseases</subject>
                        <subj-group>
                          <subject>Covid 19</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Infectious Disease Control</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Medical Risk Factors</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Virus Testing</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Social Epidemiology</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Pandemics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Optimal periodic closure for minimizing risk in emerging disease outbreaks</article-title>
                <alt-title alt-title-type="running-head">Optimal periodic closure for minimizing risk in emerging disease outbreaks</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7051-7978</contrib-id>
                  <name>
                    <surname>Hindes</surname>
                    <given-names>Jason</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3367-2084</contrib-id>
                  <name>
                    <surname>Bianco</surname>
                    <given-names>Simone</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schwartz</surname>
                    <given-names>Ira B.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>U.S. Naval Research Laboratory, Washington, DC, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>IBM Almaden Research Center, San Jose, CA, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Poletto</surname>
                    <given-names>Chiara</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>INSERM, FRANCE</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors declare that they have no conflict of interest. SB’s affiliation with IBM did not alter our adherence to PLOS ONE policies on sharing data and materials.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>jason.hindes@nrl.navy.mil</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>6</day>
                <month>1</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
              <volume>16</volume>
              <issue>1</issue>
              <elocation-id>e0244706</elocation-id>
              <history>
                <date date-type="received">
                  <day>17</day>
                  <month>8</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>15</day>
                  <month>12</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0244706.pdf"/>
              <abstract>
                <p>Without vaccines and treatments, societies must rely on non-pharmaceutical intervention strategies to control the spread of emerging diseases such as COVID-19. Though complete lockdown is epidemiologically effective, because it eliminates infectious contacts, it comes with significant costs. Several recent studies have suggested that a plausible compromise strategy for minimizing epidemic risk is periodic closure, in which populations oscillate between wide-spread social restrictions and relaxation. However, no underlying theory has been proposed to predict and explain optimal closure periods as a function of epidemiological and social parameters. In this work we develop such an analytical theory for SEIR-like model diseases, showing how characteristic closure periods emerge that minimize the total outbreak, and increase predictably with the reproductive number and incubation periods of a disease– as long as both are within predictable limits. Using our approach we demonstrate a sweet-spot effect in which optimal periodic closure is maximally effective for diseases with similar incubation and recovery periods. Our results compare well to numerical simulations, including in COVID-19 models where infectivity and recovery show significant variation.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100009917</institution-id>
                      <institution>U.S. Naval Research Laboratory</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>N0001420WX00410</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7051-7978</contrib-id>
                    <name>
                      <surname>Hindes</surname>
                      <given-names>Jason</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000006</institution-id>
                      <institution>Office of Naval Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>N00001419WX01322</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7051-7978</contrib-id>
                    <name>
                      <surname>Hindes</surname>
                      <given-names>Jason</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>JH and IBS were supported through the NRL Base funding no. N0001420WX00410, as well as the Office of Naval Research no. N00001419WX01322. IBM Research provided support in the form of salary for SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="0"/>
                <page-count count="12"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec008">Supporting information</xref> files.</meta-value>
                </custom-meta>
                <custom-meta id="outbreaks">
                  <meta-name>Outbreaks</meta-name>
                  <meta-value>COVID-19</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the manuscript and its <xref ref-type="sec" rid="sec008">Supporting information</xref> files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>1 Introduction</title>
              <p>The COVID19 pandemic, caused by the novel RNA virus SARS-CoV-2 [<xref rid="pone.0244706.ref001" ref-type="bibr">1</xref>], has resulted in devastating health, economic, and social consequences. In the absence of vaccines and treatments, non-pharmaceutical intervention (NPI) strategies have been adopted to varying degrees around the world. Given the nature of the virus transmission, NPI measures have effectively reduced human contacts– both slowing the pandemic, and minimizing the risk of local outbreaks [<xref rid="pone.0244706.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0244706.ref003" ref-type="bibr">3</xref>]. The use of drastic NPI strategies in China reportedly reduced the basic reproductive number, <italic>R</italic><sub>0</sub>, to a value smaller than 1, strongly curbing the epidemic within a short period of time [<xref rid="pone.0244706.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0244706.ref004" ref-type="bibr">4</xref>]. On the other hand widespread testing protocols and contact tracing, in e.g., South Korea, significantly controlled spread during the initial phase of the pandemic [<xref rid="pone.0244706.ref005" ref-type="bibr">5</xref>]. In other countries, the implementation of NPI policies has not been as strict [<xref rid="pone.0244706.ref002" ref-type="bibr">2</xref>], with an optimistic reduction in transmission of roughly a half. To complicate the containment of the disease, early reports indicated significant amounts of pre-symptomatic and asymptomatic transmission [<xref rid="pone.0244706.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0244706.ref007" ref-type="bibr">7</xref>]. For instance, recent estimates point to asymptomatic infection accounting for around 20–30% of the total, with a similar percentage for pre-symptomatic infections [<xref rid="pone.0244706.ref008" ref-type="bibr">8</xref>]– together producing a majority. These findings have been supported by other experimental studies [<xref rid="pone.0244706.ref009" ref-type="bibr">9</xref>] and analysis of the existing data [<xref rid="pone.0244706.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0244706.ref011" ref-type="bibr">11</xref>].</p>
              <p>As NPI controls such as quarantine, social distancing and testing are enforced, it is important to understand the impact of early release and relaxation of controls on the affected populations [<xref rid="pone.0244706.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0244706.ref013" ref-type="bibr">13</xref>]. Recent studies have attempted to address how societies can vary social contacts optimally in time in order to maintain economic activity while controlling epidemics [<xref rid="pone.0244706.ref014" ref-type="bibr">14</xref>]. For instance, preliminary numerical studies suggest that periodic closure to control outbreak risk, where a population oscillates between 30-50 days of strict lockdown followed by 30-50 days of relaxed social restrictions, may efficiently contain the spread of COVID-19 and minimize economic damage [<xref rid="pone.0244706.ref015" ref-type="bibr">15</xref>]. These studies test interesting hypotheses, but cannot be immediately generalized to new emerging diseases. A basic understanding of why and when such risk minimizing strategies are effective remains unclear, and may benefit from a general analytical approach.</p>
              <p>As a first step in this direction we analyze SEIR-like models with tunable periodic contact rates. Our methods reveal the existence of a characteristic optimal period of contact-breaking between individuals that minimizes the risk of observing a large outbreak, and predicts exactly how such an optimal period depends on epidemic and social parameters. In particular, we show that the optimal period for closure increases (or decreases) predictably with <italic>R</italic><sub>0</sub> and the incubation period of a disease, and exists as long as <italic>R</italic><sub>0</sub> is below a predictable threshold, and when there is not a time-scale separation between incubation and recovery. We demonstrate analytically that periodic closure is maximally effective for containing disease outbreaks when the typical incubation and recovery periods for a disease are similar—in such cases suppressing large outbreaks with <italic>R</italic><sub>0</sub>’s as large as 4. Our results compare well to numerical simulations and are robust to the inclusion of heterogeneous infection and recovery rates, which are known to be important for modeling COVID-19 dynamics.</p>
              <p>To begin, we first consider the canonical SEIR model with a time-dependent infectious contact rate parameter, <italic>β</italic>(<italic>t</italic>). Individuals in this model are in one of four possible states: susceptible, exposed, infectious, and recovered. Following the simplest mass-action formulation of the disease dynamics, and assuming negligible background births and deaths, the fraction of susceptible (<italic>s</italic>), exposed (<italic>e</italic>), infectious (<italic>i</italic>), and recovered (<italic>r</italic>) individuals in a population satisfy the following differential equations in time (t), where dots denote time derivatives:
<disp-formula id="pone.0244706.e001"><alternatives><graphic xlink:href="pone.0244706.e001.jpg" id="pone.0244706.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mrow><mml:mover accent="true"><mml:mi>s</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives><label>(1)</label></disp-formula>
<disp-formula id="pone.0244706.e002"><alternatives><graphic xlink:href="pone.0244706.e002.jpg" id="pone.0244706.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:mrow><mml:mover accent="true"><mml:mi>e</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives><label>(2)</label></disp-formula>
<disp-formula id="pone.0244706.e003"><alternatives><graphic xlink:href="pone.0244706.e003.jpg" id="pone.0244706.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:mrow><mml:mover accent="true"><mml:mi>i</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:mi>e</mml:mi><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives><label>(3)</label></disp-formula>
<disp-formula id="pone.0244706.e004"><alternatives><graphic xlink:href="pone.0244706.e004.jpg" id="pone.0244706.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:mrow><mml:mover accent="true"><mml:mi>r</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mi>i</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math></alternatives><label>(4)</label></disp-formula></p>
              <p>Such equations are valid in in the limit of large, well-mixed populations and constitute a baseline description for the spreading of many diseases [<xref rid="pone.0244706.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0244706.ref017" ref-type="bibr">17</xref>]. Note that <italic>α</italic> is the rate at which exposed individuals become infectious, while <italic>γ</italic> is the rate at which infected individuals recover. If <italic>β</italic>(<italic>t</italic>) = <italic>β</italic><sub>0</sub> = constant, it is straightforward to show that the basic reproductive number for the SEIR model, <italic>R</italic><sub>0</sub>, which measures the average number of new infections generated by a single infectious individual in a fully susceptible population, is <italic>R</italic><sub>0</sub> = <italic>β</italic><sub>0</sub>/<italic>γ</italic> [<xref rid="pone.0244706.ref017" ref-type="bibr">17</xref>–<xref rid="pone.0244706.ref019" ref-type="bibr">19</xref>]. Note in this work when <italic>R</italic><sub>0</sub> is written as a constant (no time dependence) it should be taken to mean this value. Typical values for the <italic>R</italic><sub>0</sub> of COVID-19 range from 1–4, depending on local population contact rates [<xref rid="pone.0244706.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0244706.ref020" ref-type="bibr">20</xref>].</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>2 Methods</title>
              <p>As a simple model for periodic closure we assume a step function for <italic>β</italic>(<italic>t</italic>) with infectious contacts occurring for a period of <italic>T</italic> days with rate <italic>β</italic><sub>0</sub>, followed by no contacts for the same period, <italic>β</italic>(<italic>t</italic>) = <italic>β</italic><sub>0</sub> ⋅ mod(floor{[<italic>t</italic> + <italic>T</italic>]/<italic>T</italic>}, 2) [<xref rid="pone.0244706.ref021" ref-type="bibr">21</xref>]. A schematic of <italic>β</italic>(<italic>t</italic>) is plotted in the inlet panel of <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(a)</xref>. In <xref ref-type="supplementary-material" rid="pone.0244706.s001">S1 Appendix</xref> we show results for smoothly varying <italic>β</italic>(<italic>t</italic>) and asymmetric closure, where lockdown and open contacts occur for different amounts of time. It is demonstrated that the results presented in the main text do not qualitatively change under these generalizations. Also in <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(a)</xref>, we plot an example time-series of the infectious fraction, normalized by the initial fraction of non-susceptibles, for three different closure periods: green (short), blue (intermediate), and red (long). For periods that are not too long or short, the disease remains in a linear spreading regime (as we will show below), and therefore normalizing by the initial conditions gives time series that are initial-condition independent.</p>
              <fig id="pone.0244706.g001" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0244706.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>Periodic closure examples.</title>
                  <p>(a) fraction infectious, normalized by initial conditions, versus time for <italic>T</italic> = 10 ⋅ days (green), <italic>T</italic> = 25 ⋅ days (blue), <italic>T</italic> = 40 ⋅ days (red) closure periods. The inlet panel shows a schematic of <italic>β</italic>(<italic>t</italic>). Other model parameters are: <italic>γ</italic><sup>−1</sup> = 10 ⋅ days, <italic>α</italic><sup>−1</sup> = 8.33 ⋅ days, and <inline-formula id="pone.0244706.e005"><alternatives><graphic id="pone.0244706.e005g" xlink:href="pone.0244706.e005"/><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mi>β</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>5</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>. (b) Outbreak size versus the closure period. Curves correspond to different <italic>R</italic><sub>0</sub> = <italic>β</italic><sub>0</sub>/<italic>γ</italic>, starting from the bottom: first (<italic>R</italic><sub>0</sub> = 1.5), second (<italic>R</italic><sub>0</sub> = 1.7), …, top (<italic>R</italic><sub>0</sub> = 3.3). Other model parameters are identical to (a).</p>
                </caption>
                <graphic xlink:href="pone.0244706.g001"/>
              </fig>
              <p>Intuitively, since the incubation period, <italic>α</italic><sup>−1</sup>, is finite, it takes time to build-up infection from small initial values. As a consequence, we expect that it may be possible to allow some disease exposure, before cutting contacts, and the result may be a net reduction in infection at the end of a closure period. For instance, notice that all <italic>i</italic>(<italic>t</italic>) decrease over a full closure cycle, 2<italic>T</italic>, in <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(a)</xref>. If the closure period is too small, infection can still grow (e.g., as <italic>T</italic> → 0, <italic>R</italic><sub>0</sub>(<italic>t</italic>) ∼ 〈<italic>R</italic><sub>0</sub>(<italic>t</italic>)〉<sub><italic>t</italic></sub> = <italic>R</italic><sub>0</sub>/2 which could be above the epidemic threshold), while if the period is too long, a large outbreak will occur before the control is applied. Between these two limits, there should be an optimal <italic>T</italic> (<italic>T</italic><sub>min</sub>), that results in a minimum outbreak. To illustrate, in <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(b)</xref> we show an example of the final outbreak-size, <italic>r</italic>(<italic>t</italic> → ∞) ≡ <italic>r</italic><sub><italic>f</italic></sub> starting from <italic>i</italic>(<italic>t</italic> = 0) = 10<sup>−3</sup>, as a function of the closure period for different, equally spaced values of <italic>R</italic><sub>0</sub>: the bottom curves correspond to smaller values of <italic>R</italic><sub>0</sub>, while the top curves correspond to larger values.</p>
              <p>As expected from the above intuitive argument, simulations show an optimal period that minimizes <italic>r</italic><sub><italic>f</italic></sub>. A natural question is, how does <italic>T</italic><sub><italic>min</italic></sub> depend on model parameters? Our approach in the following is to develop theory for <italic>T</italic><sub>min</sub> in the SEIR-model, and then show how such a theory can be easily adapted to predict <italic>T</italic><sub>min</sub> in more complete models, e.g., in COVID-19 models that include heterogeneous infectivity and asymptomatic spread [<xref rid="pone.0244706.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0244706.ref020" ref-type="bibr">20</xref>].</p>
            </sec>
            <sec sec-type="results" id="sec003">
              <title>3 Results</title>
              <sec id="sec004">
                <title>3.1 Optimal control</title>
                <p>It is possible to estimate <italic>T</italic><sub>min</sub> by calculating its value in the linearized SEIR model, applicable when the fraction of non-susceptibles is relatively small. When <italic>e</italic>(<italic>t</italic>), <italic>i</italic>(<italic>t</italic>), <italic>r</italic>(<italic>t</italic>), 1 − <italic>s</italic>(<italic>t</italic>) ≪ 1, the dynamics of Eqs <xref ref-type="disp-formula" rid="pone.0244706.e001">(1)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e004">(4)</xref> are effectively driven by a 2-dimensional system:
<disp-formula id="pone.0244706.e006"><alternatives><graphic xlink:href="pone.0244706.e006.jpg" id="pone.0244706.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mo mathvariant="bold">Ψ</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mi mathvariant="bold">M</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>·</mml:mo><mml:mo mathvariant="bold">Ψ</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula>
<disp-formula id="pone.0244706.e007"><alternatives><graphic xlink:href="pone.0244706.e007.jpg" id="pone.0244706.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi mathvariant="bold">M</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mo>[</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mo>-</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mi>a</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo>]</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula>
where <italic>a</italic> ≡ <italic>α</italic>/<italic>γ</italic>, <italic>R</italic><sub>0</sub>(<italic>t</italic>) ≡ <italic>β</italic>(<italic>t</italic>)/<italic>γ</italic>, and <bold>Ψ</bold>(<italic>t</italic>)<sup>⊤</sup> = [<italic>e</italic>(<italic>t</italic>), <italic>i</italic>(<italic>t</italic>)].</p>
                <p>The first step in calculating <italic>T</italic><sub>min</sub> is to construct eigen-solutions of Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e007">(6)</xref> in the form
<disp-formula id="pone.0244706.e008"><alternatives><graphic xlink:href="pone.0244706.e008.jpg" id="pone.0244706.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msup><mml:mo mathvariant="bold">Ψ</mml:mo><mml:mi>p</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>ν</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>·</mml:mo><mml:msup><mml:mo mathvariant="bold">Ψ</mml:mo><mml:mi>p</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula>
where <italic>ν</italic>(<italic>T</italic>) is the largest such eigenvalue; the superscript <italic>p</italic> denotes the corresponding principal eigenvector. Ignoring the subdominant eigenvalues assumes that after a sufficiently large number of iterations of periodic closure, the dynamics is well aligned with the principle solution no matter what the initial conditions. Unless stated otherwise, simulations are started in this state so that initial-condition effects are minimized. The second step is to calculate the integrated incidence, <italic>r</italic>(2<italic>T</italic>) from the solution of <xref ref-type="disp-formula" rid="pone.0244706.e008">Eq (7)</xref>, by integrating <italic>i</italic>(<italic>t</italic>) over a full cycle
<disp-formula id="pone.0244706.e009"><alternatives><graphic xlink:href="pone.0244706.e009.jpg" id="pone.0244706.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>T</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mo>[</mml:mo><mml:msup><mml:mo mathvariant="bold">Ψ</mml:mo><mml:mi>p</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:mo>·</mml:mo><mml:mi>γ</mml:mi><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula>
where [<bold>Ψ</bold><sup><italic>p</italic></sup>(<italic>t</italic>)]<sub>2</sub> denotes the infectious-component of <bold>Ψ</bold><sup><italic>p</italic></sup>(<italic>t</italic>). The third step is to calculate the final outbreak size from <italic>r</italic>(2<italic>T</italic>). To this end, it is important to realize that as long as <italic>ν</italic>(<italic>T</italic>) &lt; 1, the outbreak will decrease <italic>geometrically</italic> after successive closure cycles, and therefore <italic>r</italic><sub><italic>f</italic></sub>(<italic>T</italic>) = <italic>r</italic>(2<italic>T</italic>) + <italic>ν</italic>(<italic>T</italic>)<italic>r</italic>(2<italic>T</italic>) + <italic>ν</italic>(<italic>T</italic>)<sup>2</sup>
<italic>r</italic>(2<italic>T</italic>) + …, or
<disp-formula id="pone.0244706.e010"><alternatives><graphic xlink:href="pone.0244706.e010.jpg" id="pone.0244706.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mi>f</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>ν</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula></p>
                <p>Finally, we can find the local minimum of <italic>r</italic><sub><italic>f</italic></sub>(<italic>T</italic>) when <italic>ν</italic>(<italic>T</italic>) &lt; 1 by solving
<disp-formula id="pone.0244706.e011"><alternatives><graphic xlink:href="pone.0244706.e011.jpg" id="pone.0244706.e011g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M11"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mo>|</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mtext>min</mml:mtext></mml:msub></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(10)</label></disp-formula></p>
                <p>This algorithm gives a single fixed-point equation that determines <italic>T</italic><sub>min</sub>.</p>
                <p>Since our analysis is based on a piecewise 2-dimensional linear system, it is possible to give every quantity in the previous paragraph an exact expression [<xref rid="pone.0244706.ref022" ref-type="bibr">22</xref>] in terms of epidemiological and social parameters. See <xref ref-type="supplementary-material" rid="pone.0244706.s001">S1 Appendix</xref> for full derivation and exact expressions for Eqs <xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e011">(10)</xref>. Following our procedure gives the prediction curves shown in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(a)</xref>. The solid red line indicates the solution to <xref ref-type="disp-formula" rid="pone.0244706.e011">Eq (10)</xref>, and agrees well with simulation-determined minima of <italic>r</italic><sub><italic>f</italic></sub>(<italic>T</italic>) over a range of <italic>R</italic><sub>0</sub> given initial fractions of infectious 10<sup>−6</sup> (circles), 10<sup>−4</sup> (squares), and 10<sup>−2</sup> (diamonds). The simulation-determined minima are computed from <italic>r</italic><sub><italic>f</italic></sub>(<italic>T</italic>) curves like <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(b)</xref>. It is important to note that our optimal-control theory assumes the validity of the linearized SEIR model, applicable when the total outbreak size, <italic>r</italic><sub><italic>f</italic> ≪ 1</sub>. In general, the total outbreak size will increase with the initial fraction of infectious and <italic>R</italic><sub>0</sub>, and hence, the larger both are, the more simulations will disagree with theory. For example, this explains the better agreement for initial fractions of infectious 10<sup>−6</sup>, as compared to 10<sup>−2</sup> in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(b)</xref>.</p>
                <fig id="pone.0244706.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244706.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Optimal periodic closure.</title>
                    <p>(a) Period versus <italic>R</italic><sub>0</sub> = <italic>β</italic><sub>0</sub>/<italic>γ</italic>. The solid-red and dashed lines are theoretical predictions (exact and approximate, respectively), and the points are simulation-determined minima for initial fractions infectious: 10<sup>−6</sup> (circles), 10<sup>−4</sup> (squares), and 10<sup>−2</sup> (diamonds). The blue and dotted curves are predictions for the threshold closure period (exact and approximate, respectively). Other model parameters are: <italic>γ</italic><sup>−1</sup> = 10 ⋅ days and <italic>α</italic><sup>−1</sup> = 8.33 ⋅ days. (b) A refocused version of (a) for smaller values of <italic>R</italic><sub>0</sub>. (c) Period versus <italic>a</italic> = <italic>α</italic>/<italic>γ</italic>. The color scheme and parameters are identical to (a), except <italic>β</italic><sup>−1</sup> = 5.55 ⋅ days.</p>
                  </caption>
                  <graphic xlink:href="pone.0244706.g002"/>
                </fig>
                <p>On the other hand, the solid blue line in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(a)</xref> indicates the threshold closure period, satisfying
<disp-formula id="pone.0244706.e012"><alternatives><graphic xlink:href="pone.0244706.e012.jpg" id="pone.0244706.e012g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M12"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>ν</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mtext>thresh</mml:mtext></mml:msub><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(11)</label></disp-formula></p>
                <p>The closure period <italic>T</italic><sub>thresh</sub> results in the largest eigenvalue of Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e007">(6)</xref> equalling unity such that the principal component of exposed and infectious fractions is unchanged after a full closure cycle. If <italic>T</italic> &lt; <italic>T</italic><sub>thresh</sub>, <italic>ν</italic>(<italic>T</italic>) &gt; 1 and a large outbreak occurs, even with closure, as infection grows over a full cycle for any small non-zero <bold>Ψ</bold>(0). Given this property, <italic>T</italic><sub>thresh</sub> gives a lower bound for the optimal period, <italic>T</italic><sub>min</sub> &gt; <italic>T</italic><sub>thresh</sub>. Note: the red curve is always above the blue curve in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(a)</xref>.</p>
                <p>Before analyzing Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e011">(10)</xref> further, we point out two basic dependencies in the (normalized) optimal period <italic>T</italic><sub><italic>min</italic></sub> ⋅ <italic>γ</italic>. The first is intuitive: as the reproductive number <italic>R</italic><sub>0</sub> increases, so does <italic>T</italic><sub><italic>min</italic></sub> ⋅ <italic>γ</italic>. Hence, the faster a disease spreads the longer a population’s closure-cycle must be in order to contain it. The second is more interesting. Notice in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(c)</xref> that <italic>T</italic><sub><italic>min</italic></sub> ⋅ <italic>γ</italic> → ∞ as <italic>a</italic> → 0, and <italic>T</italic><sub><italic>min</italic></sub> ⋅ <italic>γ</italic> → 0 as <italic>a</italic> → ∞. Therefore, recalling <italic>a</italic> = <italic>α</italic>/<italic>γ</italic>, if a disease has a long incubation period, then the optimal closure cycle is similarly long. On the other hand, if a disease has a short incubation period, then the optimal closure cycle is short. In order for periodic closure to be a practical strategy, with <italic>a finite</italic>
<italic>T</italic><sub><italic>min</italic></sub>, our results indicate that <inline-formula id="pone.0244706.e013"><alternatives><graphic xlink:href="pone.0244706.e013.jpg" id="pone.0244706.e013g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M13"><mml:mrow><mml:mi>a</mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="script">O</mml:mi><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, roughly speaking, or that the recovery and incubation periods should be on the same time scale– a condition that generally applies to acute infections [<xref rid="pone.0244706.ref019" ref-type="bibr">19</xref>].</p>
                <p>Another observation from our approach that we can make is that periodic closure is not an effective strategy for arbitrarily large <italic>R</italic><sub>0</sub>, as one might expect. One way to see this from the analysis is to notice that the <italic>optimal period diverges for the linear system</italic> at some <inline-formula id="pone.0244706.e014"><alternatives><graphic xlink:href="pone.0244706.e014.jpg" id="pone.0244706.e014g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M14"><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:math></alternatives></inline-formula>, as <italic>T</italic><sub>thresh</sub> → <italic>T</italic><sub>min</sub> → ∞ (at fixed <italic>a</italic>). This transition can be seen in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2(a)</xref>, as the blue and red curves collide. Above the transition <inline-formula id="pone.0244706.e015"><alternatives><graphic xlink:href="pone.0244706.e015.jpg" id="pone.0244706.e015g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M15"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&gt;</mml:mo><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula>, no periodic closure can keep a disease from growing over a cycle. In this sense <inline-formula id="pone.0244706.e016"><alternatives><graphic xlink:href="pone.0244706.e016.jpg" id="pone.0244706.e016g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula> gives an upper bound on contact rates between individuals that can be suppressed by periodic-closure as a control strategy. We note that an optimal <italic>T</italic><sub>min</sub> still exists even when our linear approximation no longer applies, e.g., <inline-formula id="pone.0244706.e017"><alternatives><graphic xlink:href="pone.0244706.e017.jpg" id="pone.0244706.e017g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M17"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&gt;</mml:mo><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> (in the sense that <italic>r</italic>(<italic>t</italic> → ∞) is minimized by some <italic>T</italic><sub>min</sub>), but the benefit of control becomes smaller and smaller as <italic>R</italic><sub>0</sub> is increased, and the optimal period becomes increasingly dependent on initial conditions. In such cases, one must resort to numerical simulations of the full non-linear system, Eqs <xref ref-type="disp-formula" rid="pone.0244706.e001">(1)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e004">(4)</xref>.</p>
                <p>A sharper analytical understanding can be found by making the additional approximation that <bold>Ψ</bold>(<italic>t</italic>) ∼ exp[λ<sub>11</sub>
<italic>γt</italic>]<bold>v</bold><sub>11</sub>, for <italic>t</italic> &lt; <italic>T</italic> and <italic>β</italic>(<italic>t</italic>) = <italic>β</italic><sub>0</sub>, where
<disp-formula id="pone.0244706.e018"><alternatives><graphic xlink:href="pone.0244706.e018.jpg" id="pone.0244706.e018g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M18"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:mi>a</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msqrt><mml:mrow><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>4</mml:mn><mml:mi>a</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msqrt></mml:mrow><mml:mn>2</mml:mn></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(12)</label></disp-formula></p>
                <p><xref ref-type="disp-formula" rid="pone.0244706.e018">Eq (12)</xref> is the largest eigenvalue of <bold>M</bold>(<italic>t</italic>&lt;<italic>T</italic>) with eigenvector <bold>v</bold><sub>11</sub>. Hence, we ignore the time-decaying part, <bold>Ψ</bold>(<italic>t</italic>)<sub>dec</sub> ∼ exp[−(<italic>a</italic> + 1 + λ<sub>11</sub>)<italic>γt</italic>]<bold>v</bold><sub>12</sub>, of a general solution where <bold>v</bold><sub>12</sub> is the other eigenvector of <bold>M</bold>(<italic>t</italic>&lt;<italic>T</italic>). Our assumption becomes increasingly accurate with increasing <italic>T</italic>, and Eqs <xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e012">(11)</xref> simplify significantly:
<disp-formula id="pone.0244706.e019"><alternatives><graphic xlink:href="pone.0244706.e019.jpg" id="pone.0244706.e019g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M19"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mi>ν</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>γ</mml:mi><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub></mml:mrow></mml:msup><mml:mo>[</mml:mo><mml:mspace width="0.277778em"/><mml:mi>f</mml:mi><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>γ</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>f</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>a</mml:mi><mml:mi>γ</mml:mi></mml:mrow></mml:msup><mml:mspace width="0.277778em"/><mml:mo>]</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(13)</label></disp-formula>
<disp-formula id="pone.0244706.e020"><alternatives><graphic xlink:href="pone.0244706.e020.jpg" id="pone.0244706.e020g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M20"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>r</mml:mi><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mi>T</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mover accent="true"><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mfrac><mml:mo>≈</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>γ</mml:mi><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub></mml:mfrac><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mo>+</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mfrac><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mi>T</mml:mi><mml:mi>γ</mml:mi><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub></mml:mrow></mml:msup><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:mfrac><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>T</mml:mi><mml:mi>γ</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mi>a</mml:mi></mml:mfrac><mml:mo>-</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(14)</label></disp-formula>
where
<disp-formula id="pone.0244706.e021"><alternatives><graphic xlink:href="pone.0244706.e021.jpg" id="pone.0244706.e021g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M21"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>a</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mo>λ</mml:mo><mml:mn>11</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(15)</label></disp-formula>
and <inline-formula id="pone.0244706.e022"><alternatives><graphic xlink:href="pone.0244706.e022.jpg" id="pone.0244706.e022g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M22"><mml:mover accent="true"><mml:mi>r</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is a constant that depends on <italic>β</italic><sub>0</sub>, <italic>α</italic>, <italic>γ</italic> and initial conditions, but is independent of <italic>T</italic>. Substituting Eqs <xref ref-type="disp-formula" rid="pone.0244706.e019">(13)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e021">(15)</xref> into Eqs <xref ref-type="disp-formula" rid="pone.0244706.e011">(10)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e012">(11)</xref> gives a single fixed-point equation for the approximate <italic>T</italic><sub>min</sub> and <italic>T</italic><sub>thresh</sub> each, which can be easily solved. See <xref ref-type="supplementary-material" rid="pone.0244706.s001">S1 Appendix</xref> for further details. Examples of the approximate solutions are plotted with dotted and dashed lines in <xref ref-type="fig" rid="pone.0244706.g002">Fig 2</xref>, and are almost indistinguishable from the complete linear-theory predictions shown with solid lines.</p>
                <p>Using the simplified expressions, we can now show several interesting features of periodic closure. First, since Eqs <xref ref-type="disp-formula" rid="pone.0244706.e019">(13)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e020">(14)</xref> are exact for large <italic>T</italic>, we can determine <inline-formula id="pone.0244706.e023"><alternatives><graphic xlink:href="pone.0244706.e023.jpg" id="pone.0244706.e023g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M23"><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:math></alternatives></inline-formula> as a function of <italic>a</italic>. As <italic>T</italic> → ∞, <xref ref-type="disp-formula" rid="pone.0244706.e019">Eq (13)</xref> has two scaling limits depending on whether <italic>a</italic> ≥ 1 or <italic>a</italic> &lt; 1. In the former, the second term on the RHS of <xref ref-type="disp-formula" rid="pone.0244706.e019">Eq (13)</xref> becomes negligible. As <italic>T</italic> → ∞ the solution of <italic>ν</italic> = 1 is λ<sub>11</sub> → 1. Solving for <italic>R</italic><sub>0</sub> in λ<sub>11</sub> = 1 gives <inline-formula id="pone.0244706.e024"><alternatives><graphic xlink:href="pone.0244706.e024.jpg" id="pone.0244706.e024g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M24"><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:math></alternatives></inline-formula>. Similarly when <italic>a</italic> &lt; 1, as <italic>T</italic> → ∞ the solution of <italic>ν</italic> = 1 is λ<sub>11</sub> → <italic>a</italic>. Putting the two cases together, gives <inline-formula id="pone.0244706.e025"><alternatives><graphic xlink:href="pone.0244706.e025.jpg" id="pone.0244706.e025g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M25"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup><mml:mrow><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>, and the phase-diagram for optimal-periodic closure:
<disp-formula id="pone.0244706.e026"><alternatives><graphic xlink:href="pone.0244706.e026.jpg" id="pone.0244706.e026g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M26"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup><mml:mo>=</mml:mo><mml:mo>{</mml:mo><mml:mtable><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mi>a</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mi>a</mml:mi><mml:mo>≥</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mn>2</mml:mn><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>if</mml:mtext><mml:mspace width="4pt"/><mml:mi>a</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo/></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(16)</label></disp-formula></p>
                <p><xref ref-type="disp-formula" rid="pone.0244706.e026">Eq (16)</xref> is plotted in <xref ref-type="fig" rid="pone.0244706.g003">Fig 3</xref>. In region I, the optimal period is predicted to be finite, in which case small outbreaks can be contained by optimal closure. In region II, such outbreaks can not be contained. The blue squares plot numerically-determined thresholds for the piecewise linear system Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref> in the long closure-time limit. We compute each point by: picking a fixed value of a (starting with <italic>R</italic><sub>0</sub> = 2), solving for <italic>T</italic><sub>thresh</sub> according to Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e012">(11)</xref>, and then repeatedly incrementing <italic>R</italic><sub>0</sub> in small steps of 0.001 and solving for <italic>T</italic><sub>thresh</sub>(<italic>R</italic><sub>0</sub>; <italic>a</italic>) until it is a large number, i.e., <italic>T</italic><sub>thresh</sub>(<italic>R</italic><sub>0</sub>, <italic>a</italic>) <italic>·</italic> = 500. Note that as long as the system Eqs <xref ref-type="disp-formula" rid="pone.0244706.e001">(1)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e004">(4)</xref> is below threshold, we can always start with initial fractions of infectious and exposed that are small enough for the linear system to apply.</p>
                <fig id="pone.0244706.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244706.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>The largest reproductive number <italic>R</italic><sub>0</sub> for which periodic closure can keep an SEIR-model disease under threshold.</title>
                    <p>The two regimes are <italic>a</italic> = <italic>α</italic>/<italic>γ</italic> ≥ 1 (solid line) and <italic>a</italic> &lt; 1 (dashed line). Blue squares represent the numerically-determined threshold for the piecewise linear system Eqs <xref ref-type="disp-formula" rid="pone.0244706.e006">(5)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref> in the long closure-time limit. In region I, outbreaks are contained by optimal closure. In region II, they are not.</p>
                  </caption>
                  <graphic xlink:href="pone.0244706.g003"/>
                </fig>
                <p>There are several important cases to notice in <xref ref-type="fig" rid="pone.0244706.g003">Fig 3</xref>. The first is that <inline-formula id="pone.0244706.e027"><alternatives><graphic xlink:href="pone.0244706.e027.jpg" id="pone.0244706.e027g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M27"><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup></mml:math></alternatives></inline-formula> has a peak when <italic>a</italic> = 1 (<italic>α</italic> = <italic>γ</italic>). The implication is that periodic closure has the largest range of effectiveness, as measured by the ability to keep infection from growing over any closure-cycle, for diseases with <italic>equal</italic> exposure and recovery times. In this symmetric case, periodic closure can prevent large outbreaks as long as <italic>R</italic><sub>0</sub> &lt; 4 (compare this to the usual epidemic threshold without closure, <italic>R</italic><sub>0</sub> = 1). On the other hand, when there is a time-scale separation between incubation and recovery, <italic>a</italic> → ∞ or <italic>a</italic> → 0, the phase-diagram nicely reproduces the intuitive, time-averaged effective epidemic threshold 〈<italic>R</italic><sub>0</sub>(<italic>t</italic>)〉<sub><italic>t</italic></sub> = 1, or <inline-formula id="pone.0244706.e028"><alternatives><graphic xlink:href="pone.0244706.e028.jpg" id="pone.0244706.e028g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M28"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mtext>max</mml:mtext></mml:msubsup><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>.</p>
              </sec>
              <sec id="sec005">
                <title>3.2 COVID-19 model</title>
                <p>Now we turn our attention to more complete models that derive from the basic SEIR-model assumptions, but have more disease classes and free parameters which are necessary for accurate predictions. In particular, epidemiological predictions for COVID-19 seem to require an asymptomatic disease state, i.e., a group of people capable of spreading the disease without documented symptoms. Such asymptomatic transmission is thought to be a significant driver for the worldwide distribution of the disease [<xref rid="pone.0244706.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0244706.ref024" ref-type="bibr">24</xref>], since symptomatic individuals can be easily identified for quarantining while asymptomatics cannot (without widespread testing). Many models have been proposed to incorporate the broad spectrum of COVID-19 symptoms, as well as control strategies such as testing-plus-quarantining [<xref rid="pone.0244706.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0244706.ref020" ref-type="bibr">20</xref>]. A common feature of such models is the assumption that exposed individuals enter into one of several possible infectious states according to a prescribed probability distribution (e.g., asymptomatic, mild, severe, tested-and-infectious, etc.) with their own characteristic infection rates and recovery times. Following this general prescription, we define <italic>M</italic> infectious classes, <italic>i</italic><sub><italic>m</italic></sub>, where <italic>m</italic> ∈ {1, 2, …<italic>M</italic>}, each with its own infectious contact rate <italic>β</italic><sub><italic>m</italic></sub>(<italic>t</italic>) and recovery <italic>γ</italic><sub><italic>m</italic></sub> rate, and which appear from the exposed state with probabilities <italic>p</italic><sub><italic>m</italic></sub>. The relevant <italic>heterogeneous</italic> SEIR-model equations become
<disp-formula id="pone.0244706.e029"><alternatives><graphic xlink:href="pone.0244706.e029.jpg" id="pone.0244706.e029g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M29"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mspace width="0.277778em"/></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mi>m</mml:mi></mml:munder><mml:msub><mml:mi>β</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mi>s</mml:mi><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mi>e</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(17)</label></disp-formula>
<disp-formula id="pone.0244706.e030"><alternatives><graphic xlink:href="pone.0244706.e030.jpg" id="pone.0244706.e030g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M30"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mspace width="0.277778em"/></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>α</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mi>e</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi>i</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(18)</label></disp-formula></p>
                <p>Taking a common closure cycle for all individuals in the population, <italic>β</italic><sub><italic>m</italic></sub>(<italic>t</italic>) = <italic>β</italic><sub>0,<italic>m</italic></sub> ⋅ mod(floor{[<italic>t</italic> + <italic>T</italic>]/<italic>T</italic>}, 2) [<xref rid="pone.0244706.ref021" ref-type="bibr">21</xref>], we would like to test our method for predicting <italic>T</italic><sub>min</sub> in the more general model Eqs <xref ref-type="disp-formula" rid="pone.0244706.e029">(17)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e030">(18)</xref>, and demonstrate robustness to heterogeneity. In terms of an algorithm, we could simply repeat our approach for the effective 1 + <italic>M</italic> dimensional linear system; though, we loose analytical tractability. On the other hand, because <italic>T</italic><sub>min</sub> is well captured by a linear theory, which depends only on <italic>R</italic><sub>0</sub>, <italic>a</italic>, and <italic>γ</italic>, we might guess that quantitative accuracy can be maintained for higher dimensional models such as Eqs <xref ref-type="disp-formula" rid="pone.0244706.e029">(17)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e030">(18)</xref> by swapping in suitable values for these parameters in our SEIR-model formulas above. This is analogous to the epidemic-threshold condition (<italic>R</italic><sub>0</sub> = 1) being maintained in such models, as long as the correct value of <italic>R</italic><sub>0</sub> is assumed.</p>
                <p>The <italic>R</italic><sub>0</sub> for Eqs <xref ref-type="disp-formula" rid="pone.0244706.e029">(17)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e030">(18)</xref> is easy to derive using standard methods [<xref rid="pone.0244706.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0244706.ref018" ref-type="bibr">18</xref>],
<disp-formula id="pone.0244706.e031"><alternatives><graphic xlink:href="pone.0244706.e031.jpg" id="pone.0244706.e031g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M31"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>m</mml:mi></mml:munder><mml:msub><mml:mi>p</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(19)</label></disp-formula></p>
                <p>Note: the updated <italic>R</italic><sub>0</sub> is simply an average over the reproductive numbers for each infectious class. Using this averaging pattern as a starting point, our approach is to substitute the average values of <italic>α</italic>/<italic>γ</italic><sub><italic>m</italic></sub> and <italic>γ</italic><sub><italic>m</italic></sub>,
<disp-formula id="pone.0244706.e032"><alternatives><graphic xlink:href="pone.0244706.e032.jpg" id="pone.0244706.e032g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M32"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>a</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>m</mml:mi></mml:munder><mml:msub><mml:mi>p</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mi>α</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(20)</label></disp-formula>
<disp-formula id="pone.0244706.e033"><alternatives><graphic xlink:href="pone.0244706.e033.jpg" id="pone.0244706.e033g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M33"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>γ</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>m</mml:mi></mml:munder><mml:msub><mml:mi>p</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi>γ</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(21)</label></disp-formula>
into Eqs <xref ref-type="disp-formula" rid="pone.0244706.e008">(7)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e011">(10)</xref>, or Eqs <xref ref-type="disp-formula" rid="pone.0244706.e019">(13)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e021">(15)</xref> for approximate solutions. Namely, for the SEIR model we have an equation 0 = <italic>F</italic>(<italic>R</italic><sub>0</sub>, <italic>a</italic>, <italic>γ</italic>, <italic>T</italic><sub><italic>min</italic></sub>), where <italic>F</italic> is a function that is determined from <xref ref-type="disp-formula" rid="pone.0244706.e011">Eq (10)</xref>. Our averaging approximation entails solving the same <xref ref-type="disp-formula" rid="pone.0244706.e011">Eq (10)</xref> for <italic>T</italic><sub>min</sub>, but with parameters given by Eqs <xref ref-type="disp-formula" rid="pone.0244706.e031">(19)</xref>–<xref ref-type="disp-formula" rid="pone.0244706.e033">(21)</xref>.</p>
                <p>We point out that this approximation is not arbitrary since in the limit of heterogeneous infectivity only, <italic>γ</italic><sub><italic>m</italic></sub> = <italic>γ</italic>∀<italic>m</italic>, one solution of Eqs <xref ref-type="disp-formula" rid="pone.0244706.e029">(17)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e030">(18)</xref> is <italic>i</italic><sub><italic>m</italic></sub>(<italic>t</italic>) = <italic>p</italic><sub><italic>m</italic></sub>
<italic>i</italic>(<italic>t</italic>), where <italic>i</italic>(<italic>t</italic>) is the total fraction of the population infectious. In this case, the linearized system is still effectively 2-dimensional with parameters <italic>γ</italic>, <italic>α</italic>/<italic>γ</italic>, and <italic>R</italic><sub>0</sub>, where <italic>R</italic><sub>0</sub> is given by <xref ref-type="disp-formula" rid="pone.0244706.e031">Eq (19)</xref>. For this reason we expect our averaging approximation to be <italic>exact</italic> in the limit of heterogeneous infectivity only, and a good approximation when the variation in recovery rates is not too large.</p>
                <p>Examples are shown in <xref ref-type="fig" rid="pone.0244706.g004">Fig 4</xref>, where each panel shows results for an <italic>M</italic> = 2 model in which asymptomatics are significantly more (a) and less (b) infectious than symptomatics [<xref rid="pone.0244706.ref011" ref-type="bibr">11</xref>]. Symptomatic infectives are denoted with the subscript 1 and asymptomatics with the subscript 2. The optimal closure period is plotted versus the fraction of asymptomatics, <italic>p</italic><sub>2</sub>. Within each panel the different colors correspond to no variation in recovery rates (red), moderate variation (blue), and large variation (green). Simulation determined <italic>T</italic><sub>min</sub> are shown with points and predictions from the averaging theory shown with solid lines. The initial conditions for simulations follow the SEIR model convention– parallel to the principal solution of <xref ref-type="disp-formula" rid="pone.0244706.e008">Eq (7)</xref>, <bold>Ψ</bold><sup><italic>p</italic></sup>(0)—except that the fraction in each infectious class is <italic>i</italic><sub><italic>m</italic></sub>(0) = <italic>p</italic><sub><italic>m</italic></sub>[<bold>Ψ</bold><sup><italic>p</italic></sup>]<sub>2</sub>. The model parameters were chosen to match similar models [<xref rid="pone.0244706.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0244706.ref020" ref-type="bibr">20</xref>], which were fit to multiple COVID-19 data sources. As expected, the agreement between theory and simulations ranges from excellent to fair depending on the heterogeneity in recovery rates.</p>
                <fig id="pone.0244706.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0244706.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Optimal closure period for a heterogeneous SEIR model with symptomatic and asymptomatic infection as a function of the fraction of asymptomatics.</title>
                    <p>(a) Increased infectivity for asymptomatics, <italic>β</italic><sub>1</sub> = 2.1 ⋅ <italic>γ</italic><sub>1</sub> and <italic>β</italic><sub>2</sub> = 2.6 ⋅ <italic>γ</italic><sub>2</sub>. The solid lines are theoretical predictions and the points are simulation-determined minima for initial fractions of non-susceptibles 10<sup>−5</sup>. Each series has different recovery times: red (<inline-formula id="pone.0244706.e034"><alternatives><graphic id="pone.0244706.e034g" xlink:href="pone.0244706.e034"/><mml:math id="M34"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>10</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0244706.e035"><alternatives><graphic id="pone.0244706.e035g" xlink:href="pone.0244706.e035"/><mml:math id="M35"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>10</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>), blue (<inline-formula id="pone.0244706.e036"><alternatives><graphic id="pone.0244706.e036g" xlink:href="pone.0244706.e036"/><mml:math id="M36"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>12</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0244706.e037"><alternatives><graphic id="pone.0244706.e037g" xlink:href="pone.0244706.e037"/><mml:math id="M37"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>8</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>), and green (<inline-formula id="pone.0244706.e038"><alternatives><graphic id="pone.0244706.e038g" xlink:href="pone.0244706.e038"/><mml:math id="M38"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>14</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>, <inline-formula id="pone.0244706.e039"><alternatives><graphic id="pone.0244706.e039g" xlink:href="pone.0244706.e039"/><mml:math id="M39"><mml:mrow><mml:msubsup><mml:mi>γ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>7</mml:mn><mml:mo>·</mml:mo><mml:mtext>days</mml:mtext></mml:mrow></mml:math></alternatives></inline-formula>). The incubation period is <italic>α</italic><sup>−1</sup> = 7 ⋅ days. (b) Decreased infectivity for asymptomatics. Model parameters are identical to (a) except <italic>β</italic><sub>2</sub> = 1.5 ⋅ <italic>γ</italic><sub>2</sub>.</p>
                  </caption>
                  <graphic xlink:href="pone.0244706.g004"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec006">
              <title>4 Discussion</title>
              <p><xref ref-type="fig" rid="pone.0244706.g004">Fig 4</xref> demonstrates that the optimal closure period for COVID-19 can depend significantly on the amount of asymptomatic spread, particularly if there is a large difference in infection rates compared to symptomatic cases. Since asymptomatic spread is difficult to measure directly, especially in the early stages of an emerging disease outbreak, it may be difficult to estimate the optimal control accurately enough for periodic closure to be an actionable strategy on its own. A possible solution is to deploy effective and widespread testing within a population, <italic>early</italic>, and capture the fraction of asymptomatic infections. In any case, if basic parameters are known for an emerging disease dynamics, periodic closure is very effective—producing large reductions in the final outbreak size (e.g., <xref ref-type="fig" rid="pone.0244706.g001">Fig 1(b)</xref>)– and can be predicted using our methods.</p>
              <p>An additional component of population heterogeneity not treated in this work is age dependence, which is known to be particularly important for modelling the COVID-19 pandemic. When considering expanded models that include age compartments, various mixing mechanisms across age groups generate different reproductive rates of infection [<xref rid="pone.0244706.ref025" ref-type="bibr">25</xref>–<xref rid="pone.0244706.ref027" ref-type="bibr">27</xref>]. One extreme compartmented grouping is to decompose a population into young, middle aged, and seniors with age-dependent contact rates between groups, age-dependent recovery periods, and some modest age-dependence in incubation periods. Under weak inter-age mixing assumptions, the result is a system of equations similar to Eqs <xref ref-type="disp-formula" rid="pone.0244706.e029">(17)</xref> and <xref ref-type="disp-formula" rid="pone.0244706.e030">(18)</xref>. As demonstrated in Sec.3.2, the emergence of an optimal periodic control depends primarily on <italic>R</italic><sub>0</sub> and the mean incubation period, and persists in spite of population heterogeneity. Although our controls are based on mean epidemiological parameters, it is easy to see how such controls may be distributed across age-dependent groups, and/or spatial clusters. Thus, we expect the inclusion of age-dependent effects to quantitatively change the results presented, but leave our methodology and qualitative findings intact.</p>
              <p>Finally, we should remark that in addition to the heterogeneity discussed, parameter fluctuations for COVID-19 spread can occur in space and time. In fact, noise in reporting, differences in local policies, and adherence to the various forms of intervention may cause drastic fluctuations in the local spreading parameters. Given these facts, the well-mixed nature of our model may be insufficient to provide accurate optimal-control predictions. In such cases, a meta-population or network framework may be more appropriate. Yet, the approach that we lay out can be naturally generalized to more accurate and heterogeneous contact-network models, particularly since SIR and SEIR model dynamics on random networks can be described by relatively low-dimensional dynamical systems [<xref rid="pone.0244706.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0244706.ref031" ref-type="bibr">31</xref>], which could be analyzed using the methods described in Sec.2. For small levels of infection, the main contribution from contact heterogeneity is to increase the effective, network <italic>R</italic><sub>0</sub>. Once the correct <italic>R</italic><sub>0</sub> is assumed, however, we expect the network results to be similar to those presented here, though this is a subject for future study.</p>
            </sec>
            <sec sec-type="conclusions" id="sec007">
              <title>5 Conclusion</title>
              <p>In conclusion, a main socio-economic issue with an emerging virus, in the absence of vaccines and treatments, is the enormous damage at all levels of a population. Here we considered a simple approach to model and control an emerging virus outbreak with a finite incubation period. We show that by tuning periodic control of social contact rates, there exists an optimal period that naturally minimizes the outbreak size of the disease, as long as the reproductive number is below a predictable threshold and there is not a time-scale separation between incubation and recovery. Our basic assumption for the existence of such an optimal control rests on early detection of the disease, in which non-susceptible populations are small. Such a basic assumption allows one to analytically predict the optimal period, and provide parameter regions in which an optimal control exists. While in general it has been suggested that periodic closure may help curb the spread of an infectious disease like COVID-19, the implementation of such measures has been, to the best of our knowledge, mostly based on observations of recovery periods and absence of new cases for a given period of time. In this paper, we provide a general formulation that can be utilized to rationally design optimal intervention release protocols. While we start from an SEIR model and expand to heterogeneous models that capture the basic dynamics of COVID-19, our theory can be generally applied to acute infections, with the caveat that recovery and incubation periods should be roughly on the same time scale.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec008">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0244706.s001">
                <label>S1 Appendix</label>
                <caption>
                  <title>Optimal control analysis.</title>
                  <p>Supporting calculations and derivation of the outbreak-minimizing periodic control for the SEIR model. Additional simulation and analysis for both smooth and asymmetric control.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0244706.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors acknowledge useful discussions with the IBM COVID19 modeling taskforce.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0244706.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Horby</surname><given-names>PW</given-names></name>, <name><surname>Hayden</surname><given-names>FG</given-names></name>, <name><surname>Gao</surname><given-names>GF</given-names></name>. <article-title>A novel coronavirus outbreak of global health concern</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>470</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30185-9</pub-id>
<?supplied-pmid 31986257?><pub-id pub-id-type="pmid">31986257</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand</article-title>. <source>Imperial College COVID-19 Response Team</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.25561/77482</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>C</given-names></name>, <etal>et al</etal><article-title>Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China</article-title>. <source>medRxiv</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.101/2020.03.03.20030593</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China</article-title>. <source>JAMA</source>. <year>2020</year>;<volume>323</volume>(<issue>19</issue>):<fpage>1915</fpage><pub-id pub-id-type="doi">10.1001/jama.2020.6130</pub-id><?supplied-pmid 32275295?><pub-id pub-id-type="pmid">32275295</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>J</given-names></name>, <name><surname>Kupferschmidt</surname><given-names>K</given-names></name>. <article-title>Countries test tactics in ‘war’ against COVID-19</article-title>. <source>Science</source>. <year>2020</year>;<volume>367</volume>(<issue>6484</issue>):<fpage>1287</fpage>–<lpage>1288</lpage>. <pub-id pub-id-type="doi">10.1126/science.367.6484.1287</pub-id>
<?supplied-pmid 32193299?><pub-id pub-id-type="pmid">32193299</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)</article-title>. <source>Science</source>. <year>2020</year>;<volume>368</volume>(<issue>6490</issue>):<fpage>489</fpage>–<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id>
<?supplied-pmid 32179701?><pub-id pub-id-type="pmid">32179701</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <etal>et al</etal><article-title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia</article-title>. <source>New England Journal of Medicine</source>. <year>2020</year>;<volume>382</volume>(<issue>13</issue>):<fpage>1199</fpage>–<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>
<?supplied-pmid 31995857?><pub-id pub-id-type="pmid">31995857</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Moghadas</surname><given-names>SM</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>MC</given-names></name>, <name><surname>Sah</surname><given-names>P</given-names></name>, <name><surname>Pandey</surname><given-names>A</given-names></name>, <name><surname>Shoukat</surname><given-names>A</given-names></name>, <name><surname>Singer</surname><given-names>BH</given-names></name>, <etal>et al</etal><article-title>The implications of silent transmission for the control of COVID-19 outbreaks</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2020</year>;<volume>117</volume>(<issue>30</issue>):<fpage>17513</fpage>–<lpage>17515</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2008373117</pub-id>
<?supplied-pmid 32632012?><pub-id pub-id-type="pmid">32632012</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Sutton</surname><given-names>D</given-names></name>, <name><surname>Fuchs</surname><given-names>K</given-names></name>, <name><surname>D’Alton</surname><given-names>M</given-names></name>, <name><surname>Goffman</surname><given-names>D</given-names></name>. <article-title>Universal Screening for SARS-CoV-2 in Women Admitted for Delivery</article-title>. <source>New England Journal of Medicine</source>. <year>2020</year>;<volume>382</volume>(<issue>22</issue>):<fpage>2163</fpage>–<lpage>2164</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2009316</pub-id>
<?supplied-pmid 32283004?><pub-id pub-id-type="pmid">32283004</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>G</given-names></name>, <etal>et al</etal><article-title>Explaining the Bomb-Like Dynamics of COVID-19 with Modeling and the Implications for Policy</article-title>. <source>medRxiv</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1101/2020.04.05.20054338</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>IB</given-names></name>, <name><surname>Kaufman</surname><given-names>JH</given-names></name>, <name><surname>Hu</surname><given-names>K</given-names></name>, <name><surname>Bianco</surname><given-names>S</given-names></name>. <article-title>Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19</article-title><source>COVID19</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1101/2020.04.16.20068387</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>H</given-names></name>, <name><surname>Feng</surname><given-names>Z</given-names></name>. <article-title>Staggered release policies for COVID-19 control: Costs and benefits of relaxing restrictions by age and risk</article-title>. <source>Mathematical Biosciences</source>. <year>2020</year>;<volume>326</volume>:<fpage>108405</fpage><pub-id pub-id-type="doi">10.1016/j.mbs.2020.108405</pub-id><?supplied-pmid 32565231?><pub-id pub-id-type="pmid">32565231</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref013">
                <label>13</label>
                <mixed-citation publication-type="other">Serra M, et al. Optimal policies for mitigating pandemic costs. arXiv:200711178 [physicssoc-ph]. 2020;.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Karin</surname><given-names>O</given-names></name>, <etal>et al</etal><article-title>Cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity</article-title>. <source>medRxiv</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1101/2020.04.04.20053579</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Chowdhury</surname><given-names>R</given-names></name>, <etal>et al</etal><article-title>Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries</article-title>. <source>European Journal of Epidemiology</source>. <year>2020</year>;<volume>35</volume>(<issue>5</issue>):<fpage>389</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-020-00649-w</pub-id>
<?supplied-pmid 32430840?><pub-id pub-id-type="pmid">32430840</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Aron</surname><given-names>JL</given-names></name>, <name><surname>Schwartz</surname><given-names>IB</given-names></name>. <article-title>Seasonality and period-doubling bifurcations in an epidemic model</article-title>. <source>J Theor Biol</source>. <year>1984</year>;<volume>110</volume>(<issue>4</issue>):<fpage>665</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5193(84)80150-2</pub-id>
<?supplied-pmid 6521486?><pub-id pub-id-type="pmid">6521486</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref017">
                <label>17</label>
                <mixed-citation publication-type="book"><name><surname>Keeling</surname><given-names>M</given-names></name>, <name><surname>Rohani</surname><given-names>P</given-names></name>. <source>Modeling Infectious Diseases in Humans and Animals</source>. <publisher-name>Princeton University Press</publisher-name>; <year>2007</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Hefferman</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>R</given-names></name>, <name><surname>Wahl</surname><given-names>L</given-names></name>. <article-title>Perspectives on the basic reproduction ratio</article-title>. <source>J R Soc Interface</source>;<volume>2</volume>:<fpage>281</fpage><pub-id pub-id-type="doi">10.1098/rsif.2005.0042</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref019">
                <label>19</label>
                <mixed-citation publication-type="book"><name><surname>Anderson</surname><given-names>RM</given-names></name>, <name><surname>May</surname><given-names>RM</given-names></name>. <source>Infectious Diseases of Humans: Dynamics and Control</source>. <publisher-name>Oxford University Press</publisher-name>; <year>1991</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Kerr</surname><given-names>CC</given-names></name>, <etal>et al</etal><article-title>Covasim: an agent-based model of COVID-19 dynamics and interventions</article-title>. <source>medRxiv</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1101/2020.05.10.20097469</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref021">
                <label>21</label>
                <mixed-citation publication-type="other">The floor function rounds its argument down to the nearest integer while mod(<italic>x</italic>, 2) denotes the remainder of integer-division of <italic>x</italic> by 2;.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref022">
                <label>22</label>
                <mixed-citation publication-type="book"><name><surname>Strogatz</surname><given-names>S</given-names></name>. <source>Nonlinear Dynamics and Chaos: With Applications to Physics, Biology, Chemistry, and Engineering</source>. <publisher-name>Westview Press</publisher-name>; <year>2015</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Chinazzi</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak</article-title>. <source>Science</source>. <year>2020</year>;<volume>368</volume>:<fpage>395</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1126/science.aba9757</pub-id><pub-id pub-id-type="pmid">32144116</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Lavezzo</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’</article-title>. <source>Nature</source>. <year>2020</year>; p. [epub ahead of print]. <pub-id pub-id-type="doi">10.1038/s41586-020-2488-1</pub-id><?supplied-pmid 32604404?><pub-id pub-id-type="pmid">32604404</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref025">
                <label>25</label>
                <mixed-citation publication-type="book"><name><surname>Blyuss</surname><given-names>KB</given-names></name>, <name><surname>Kyrychko</surname><given-names>YN</given-names></name>. <source>Effects of latency and age structure on the dynamics and containment of COVID-19</source>. <year>2020</year>; <pub-id pub-id-type="doi">10.1101/2020.04.25.20079848</pub-id>.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Hilton</surname><given-names>J</given-names></name>, <name><surname>Keeling</surname><given-names>MJ</given-names></name>. <article-title>Estimation of country-level basic reproductive ratios for novel Coronavirus (SARS-CoV-2/COVID-19) using synthetic contact matrices</article-title>. <source>PLOS Computational Biology</source>. <year>2020</year>;<volume>16</volume>(<issue>7</issue>):<fpage>e1008031</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1008031</pub-id><?supplied-pmid 32614817?><pub-id pub-id-type="pmid">32614817</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref027">
                <label>27</label>
                <mixed-citation publication-type="book"><name><surname>Wilder</surname><given-names>B</given-names></name>, <name><surname>Charpignon</surname><given-names>M</given-names></name>, <name><surname>Killian</surname><given-names>JA</given-names></name>, <name><surname>Ou</surname><given-names>HC</given-names></name>, <name><surname>Mate</surname><given-names>A</given-names></name>, <name><surname>Jabbari</surname><given-names>S</given-names></name>, <etal>et al</etal><source>Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City</source>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pone.0244706.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>JC</given-names></name>, <name><surname>S</surname><given-names>AC</given-names></name>, <name><surname>Volz</surname><given-names>EM</given-names></name>. <article-title>Edge-based compartmental modelling for infectious disease spread</article-title>. <source>JR Soc Interface</source>. <year>2012</year>;<volume>9</volume>(<issue>70</issue>):<fpage>890</fpage>–<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1098/rsif.2011.0403</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Hindes</surname><given-names>J</given-names></name>, <name><surname>Singh</surname><given-names>S</given-names></name>, <name><surname>Myers</surname><given-names>CR</given-names></name>, <name><surname>Schneider</surname><given-names>DJ</given-names></name>. <article-title>Epidemic fronts in complex networks with metapopulation structure</article-title>. <source>Phys Rev E</source>. <year>2013</year>;<volume>88</volume>:<fpage>012809</fpage><pub-id pub-id-type="doi">10.1103/PhysRevE.88.012809</pub-id><?supplied-pmid 23944520?><pub-id pub-id-type="pmid">23944520</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>R</given-names></name>, <name><surname>Lancellotti</surname><given-names>M</given-names></name>, <name><surname>Finckh</surname><given-names>A</given-names></name>, <name><surname>Shang</surname><given-names>Y</given-names></name>. <article-title>SEIR Epidemic Dynamics in Random Networks</article-title>. <source>ISRN Epidemiology</source>. <year>2013</year>;<volume>2013</volume>:<fpage>345618</fpage><pub-id pub-id-type="doi">10.5402/2013/345618</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0244706.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>IB</given-names></name>. <article-title>Small amplitude, long period outbreaks in seasonally driven epidemics</article-title>. <source>Journal of Mathematical Biology</source>. <year>1992</year>;<volume>30</volume>(<issue>5</issue>):<fpage>473</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1007/BF00160532</pub-id>
<?supplied-pmid 1578191?><pub-id pub-id-type="pmid">1578191</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
